Table 1.2 (abstract P370). See text for description
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
Patient | Diagnosis | Mean PROM Improvement (in degrees) | Median PROM Improvement (in degrees) | Goals set | Goals Met in time frame | Goals Continuing | % Met |
|---|---|---|---|---|---|---|---|
One | JIA-ERA | 16.75 | 13 | 2 | 2 | 0 | 100% |
Two | Scleroderma | 11.66 | 10 | 6 | 4 | 2 | 66% |
Three | Scleroderma | 7.77 | 5 | 5 | 0 | 5 | 0% |
Four | Scleroderma | 10.71 | 7.5 | 3 | 2 | 1 | 66% |
Five | JIA-Poly-Articular | 13.75 | 15 | 2 | 0 | 2 | 0% |
Six | JIA-ERA | NA | NA | 1 | 1 | 0 | 100% |
Seven | JIA-Oligo | NA | NA | 1 | 1 | 0 | 100% |
Eight | JDM | NA | NA | 2 | 2 | 0 | 100% |